Filter
681
Filtered Results: 681
Text search:
Lu
C.
Featured
Recommendations
59
New Publications
128
Language
Document type
No document type
296
Studies & Reports
149
Guidelines
116
Manuals
44
Training Material
29
Fact sheets
19
Strategic & Response Plan
11
Infographics
7
Brochures
5
Situation Updates
3
Dashboards/Maps
1
Resource Platforms
1
Countries / Regions
Global
35
Congo, Democratic Republic of
14
Russia
14
Burkina Faso
12
Haiti
12
Germany
12
Benin
11
Myanmar / Burma
11
Senegal
9
Vietnam
9
India
8
Indonesia
8
West and Central Africa
8
Western and Central Europe
8
Kenya
7
Cambodia
7
Latin America and the Carribbean
7
Cameroon
6
Nepal
6
Bangladesh
6
Middle East and North Africa
6
Peru
5
Brazil
5
East and Southern Africa
5
Guinea
4
Ethiopia
4
Togo
4
Philippines
4
Zambia
4
Syria
4
Rwanda
4
Central African Republic
4
Ukraine
4
Africa
4
Laos
4
Nigeria
3
South Africa
3
Madagascar
3
Yemen
3
Paraguay
3
Asia
3
Eastern Europe
3
Spain
3
Sierra Leone
2
Liberia
2
Mali
2
Uganda
2
Tanzania
2
Mozambique
2
Sudan
2
Ecuador
2
Bolivia
2
Eastern Europe and Central Asia
2
Italy
2
France
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Ghana
1
Niger
1
Pakistan
1
South Sudan
1
Iraq
1
Afghanistan
1
Lebanon
1
Malawi
1
Switzerland
1
Burundi
1
El Salvador
1
Angola
1
Sri Lanka
1
South–East Asia Region
1
Venezuela
1
Armenia
1
Tajikistan
1
Estonia
1
Romania
1
Gabon
1
Japan
1
Tunisia
1
United Kingdom
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
203
Clinical Guidelines
59
Public Health
50
Women & Child Health
38
Capacity Building
18
Key Resources
17
Pharmacy & Technologies
13
Toolboxes
COVID-19
106
Mental Health
91
Disability
38
TB
36
Planetary Health
27
NTDs
24
HIV
21
NCDs
20
Caregiver
18
Refugee
17
AMR
16
Health Financing Toolbox
15
Ebola
13
Pharmacy
13
Rapid Response
12
Natural Hazards
9
Global Health Education
9
Conflict
5
Social Ethics
4
Zika
2
Specific Hazards
2
Cholera
1
Typhoon
1
La presente publicación describe la evidencia científica publicada respecto a la hipertensión como factor pronóstico en pacientes con COVID-19. Se identificó una revisión sistemática que evaluó diferentes desenlaces de pronóstico en pacientes con hipertensión y diagnóstico confirmado de C...
La presente publicación describe la literatura científica revisada sobre las intervenciones farmacológicas para el tratamiento de la enfermedad por el coronavirus 2019. El Ministerio de Salud solicitó la revisión de la evidencia disponible para nueve intervenciones terapéuticas frente a COVID-...
La presente publicación describe un resumen de la evidencia científica disponible sobre el uso de Cloroquina e hidroxicloroquina, así como su profilaxis y tratamiento para COVID-19.
Esta publicación pertenece al compendio Publicaciones Minsa sobre COVID-19
La presente publicación describe la evidencia científica disponible sobre la utilidad del uso complementario de pruebas moleculares y de detección de anticuerpos para mejorar el diagnóstico de sospechosos de COVID-19. La utilización complementaria de ambas pruebas podría mejorar la identificac...
Cette ressource a été élaborée pour faciliter le développement de plans d’action nationaux stratégiques et bien coordonnés afin de contrer rapidement la désinformation sur les vaccins et d’encourager la demande de vaccination éclairée par l’écoute sociale.
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
Background: Cervical cancer accounts for 23% of cancer incidence and 22% of cancer mortality among women in Burkina Faso. These proportions are more than 2 and 5 times higher than those of developed countries, respectively. Before 2010, cervical cancer prevention (CECAP) services in Burkina Faso wer...
Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
Consensual Recommendation for treatment of COVID-19 in older adults
Available in English, French, Spanish and Russian from the website https://apps.who.int/iris/handle/10665/344562
Recommendations for in-patient management of COVID-19 in adult patients
Version 10, November 2020.
European Journal of Biomedical and Pharmaceutical Sciences, vol.3 (2016) 1, 192-206
This review shows that if all sub areas of pharmaceutical waste management can efficiently work back to back environmental pollution and dangers to human health can reduce significantly.
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
his guidance provides interim guidance for the integration of SARS-CoV-2 and influenza virologic and genomic surveillance, from sentinel site case enrolment and sampling to the eventual sharing of the virus sequence data, a process known as end-to-end surveillance. This guidance builds on experience...
Action Plan 2021-2025
En estas directrices se actualiza la sección de recomendaciones sobre la prevención de la transmisión maternoinfantil de las Directrices para la prevención, la atención y el tratamiento de la infección crónica por el virus de la hepatitis B, publicadas por la OMS en el 2015, y se centra la at...
